Free Trial

Millennium Management LLC Invests $9.28 Million in Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare logo with Medical background

Millennium Management LLC acquired a new position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,700,142 shares of the company's stock, valued at approximately $9,283,000. Millennium Management LLC owned about 1.44% of Definitive Healthcare as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in DH. 272 Capital LP acquired a new position in Definitive Healthcare during the second quarter worth $3,480,000. Susquehanna Fundamental Investments LLC purchased a new position in shares of Definitive Healthcare in the 1st quarter valued at about $120,000. Vanguard Group Inc. lifted its stake in shares of Definitive Healthcare by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company's stock valued at $36,600,000 after purchasing an additional 67,068 shares during the period. Boston Partners purchased a new stake in Definitive Healthcare during the first quarter worth about $550,000. Finally, Swiss National Bank grew its position in Definitive Healthcare by 2.9% during the first quarter. Swiss National Bank now owns 103,300 shares of the company's stock worth $834,000 after buying an additional 2,900 shares during the period. Institutional investors and hedge funds own 98.67% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on DH shares. JPMorgan Chase & Co. downgraded Definitive Healthcare from a "neutral" rating to an "underweight" rating and decreased their target price for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. BTIG Research initiated coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They issued a "buy" rating and a $7.00 price objective on the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Definitive Healthcare from $7.00 to $5.00 and set a "hold" rating for the company in a report on Friday, August 9th. Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a report on Tuesday, August 6th. Finally, Robert W. Baird dropped their price objective on shares of Definitive Healthcare from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $5.81.

Check Out Our Latest Analysis on DH

Definitive Healthcare Trading Up 2.1 %

Shares of Definitive Healthcare stock traded up $0.09 during trading hours on Wednesday, reaching $4.30. The stock had a trading volume of 252,278 shares, compared to its average volume of 793,024. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.27. Definitive Healthcare Corp. has a 1 year low of $3.19 and a 1 year high of $10.62. The firm has a market capitalization of $507.12 million, a price-to-earnings ratio of -2.46, a P/E/G ratio of 6.49 and a beta of 1.33. The firm has a 50 day simple moving average of $4.27 and a two-hundred day simple moving average of $5.51.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last posted its earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The business had revenue of $63.70 million for the quarter, compared to analyst estimates of $63.19 million. During the same quarter in the previous year, the business posted $0.08 EPS. The business's quarterly revenue was up 4.4% on a year-over-year basis. As a group, equities research analysts anticipate that Definitive Healthcare Corp. will post 0.07 earnings per share for the current year.

Definitive Healthcare Company Profile

(Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Read More

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Should you invest $1,000 in Definitive Healthcare right now?

Before you consider Definitive Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.

While Definitive Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines